|
SHPK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.163870E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.6444999999945E-05 |
| Normal-vs-Stage2 |
8.531900E-02 |
| Normal-vs-Stage3 |
1.102010E-02 |
| Normal-vs-Stage4 |
2.753600E-02 |
| Stage1-vs-Stage2 |
4.265400E-01 |
| Stage1-vs-Stage3 |
3.413800E-01 |
| Stage1-vs-Stage4 |
4.511400E-01 |
| Stage2-vs-Stage3 |
8.655800E-01 |
| Stage2-vs-Stage4 |
8.521200E-01 |
| Stage3-vs-Stage4 |
9.680400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.29219999999808E-05 |
| Normal-vs-AfricanAmerican |
9.705000E-03 |
| Normal-vs-Asian |
2.167800E-01 |
| Caucasian-vs-AfricanAmerican |
6.953800E-01 |
| Caucasian-vs-Asian |
1.986620E-01 |
| AfricanAmerican-vs-Asian |
2.420200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.200400E-04 |
| Normal-vs-Female |
6.372800E-04 |
| Male-vs-Female |
2.545200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.38699999999259E-05 |
| Normal-vs-Age(41-60Yrs) |
1.410000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.057530E-02 |
| Normal-vs-Age(81-100Yrs) |
8.680400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.550300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.144400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.083600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.020200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.757600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.517200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.829400E-01 |
| Classical-VS-Follicular |
9.375500E-04 |
| Classical-VS-Other |
2.823200E-01 |
| Classical-VS-Normal |
1.08769999995761E-06 |
| Tall-VS-Follicular |
9.147900E-02 |
| Tall-VS-Other |
3.487000E-01 |
| Tall-VS-Normal |
1.180150E-02 |
| Follicular-VS-Other |
9.724600E-01 |
| Follicular-VS-Normal |
5.504400E-01 |
| Other-VS-Normal |
6.887800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.983900E-03 |
| Normal-vs-N1 |
2.832600E-01 |
| N0-vs-N1 |
3.812400E-01 |
|
|
